The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2024 | Challenges in timely assessment and access to care for lung cancer
Mariana Brandao, MD, PhD, from the Institute Jules Bordet in Brussels, Belgium, discusses the challenges in timely assessment and access to care for patients with stage III lung cancer. She highlights the low percentage of patients receiving PET-CT scans within the required timeframe and the disparities in access to brain MRI and pathological nodal staging. Dr Brandao emphasizes the importance of functional operability assessments, including exercise testing and rehabilitation, in improving surgical outcomes. This interview took place at the BTOG 2024 congress in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
